PMA

P150040: VISUMAX FEMTOSECOND LASER

FDA PMA · Femtosecond laser system for refractive correction · Carl Zeiss Meditec, Inc.

Key facts

PMA number P150040
Trade name VISUMAX FEMTOSECOND LASER
Generic name Femtosecond laser system for refractive correction
Applicant Carl Zeiss Meditec, Inc.
Owner/operator Carl Zeiss Meditec AG (Jena)
Product code OTL
Approval date Sep 13, 2016
Docket number 16M-2735
Notice date Sep 16, 2016
Establishment registration 2918630
FEI number 2918630

At a glance

  • 10–99 Supplements
  • May 26, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals